Vicore Pharma Holding AB

Overview

Compare with another stock.

• TickerVCRE on Nasdaq¹
• IndustryPharmaceutical Preparations¹
• HeadquartersV7¹
• Incorporated inSweden²
• Business addressKornhamnstorg 53, Stockholm, 111 27²

See how the biggest companies compare on our leaderboards

Corporate structure

Vicore Pharma Holding AB sits at the top of its group. 1 entity on record. Switch between the flow chart and the network, and select any entity to see its details.

Built from major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

Filings

10 filings to the SEC since October 2021: 1 large holders, 9 other. The latest 10:

1. Oct 13, 2026SCHEDULE 13G EDGAR
2. Sep 30, 20266-K EDGAR
3. Aug 21, 2026S-8 EDGAR
4. Aug 21, 20266-K EDGAR
5. Jul 6, 20266-K EDGAR
6. Jun 30, 2026SEC STAFF ACTION EDGAR
7. Jun 30, 2026CERT EDGAR
8. Jun 9, 202620FR12B/A EDGAR
9. May 22, 202620FR12B EDGAR
10. Apr 17, 2026DRS EDGAR

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

• HBM Healthcare Investments (Cayman) Ltd.SCHEDULE 13G, 1 filing Oct 13, 2026³

SEC filer profile

How Vicore Pharma Holding AB is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

• Name on EDGARVicore Pharma Holding AB¹
• CIK0002124403
• Incorporated inSweden¹
• Fiscal year endsDecember 31¹
• Industry code (SIC)2834 Pharmaceutical Preparations¹
• SEC reviewing officeOffice of Life Sciences, Division of Corporation Finance¹
• Business addressKornhamnstorg 53, Stockholm, 111 27, Sweden¹
• Phone46(0)317880560¹
• On EDGAR sinceApr 17, 2026¹
• Filings10 in all: 6-K (3), 20FR12B (1), 20FR12B/A (1), CERT (1), DRS (1), S-8 (1), SCHEDULE 13G (1), SEC STAFF ACTION (1)¹